Cargando…

Study on the expression of PAK4 and P54 protein in breast cancer

BACKGROUND: Previous evidence have demonstrated that p21-activated kinase PAK4 was correlated with breast cancer. The aim of this paper is to study the expression and interaction of p21-activated kinase (pAK)-4 and P54 protein in breast cancer. METHODS: A total of 80 patients were enrolled in our st...

Descripción completa

Detalles Bibliográficos
Autores principales: Bi, Yanqing, Tian, Mengzi, Le, Jinghong, Wang, Linlin, Liu, Xiaofang, Qu, Jianhua, Hao, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906770/
https://www.ncbi.nlm.nih.gov/pubmed/27297086
http://dx.doi.org/10.1186/s12957-016-0913-6
_version_ 1782437469066625024
author Bi, Yanqing
Tian, Mengzi
Le, Jinghong
Wang, Linlin
Liu, Xiaofang
Qu, Jianhua
Hao, Min
author_facet Bi, Yanqing
Tian, Mengzi
Le, Jinghong
Wang, Linlin
Liu, Xiaofang
Qu, Jianhua
Hao, Min
author_sort Bi, Yanqing
collection PubMed
description BACKGROUND: Previous evidence have demonstrated that p21-activated kinase PAK4 was correlated with breast cancer. The aim of this paper is to study the expression and interaction of p21-activated kinase (pAK)-4 and P54 protein in breast cancer. METHODS: A total of 80 patients were enrolled in our study (breast fibroma n = 20, breast noninvasive cancer n = 20, early breast invasive cancer n = 20, and advanced breast invasive cancer). The expression of PAK4 was detected by immunohistochemical S-P method, and the relationship between them and the different pathological characteristics were compared. The subcellular localization of P54 and PAK4 in vitro was observed by immunofluorescence assay. RESULTS: The expression of both PAK4 and P54 in breast cancer was much higher than that in breast fibroma. Meanwhile, we found that both PAK4 and P54 increased gradually as breast cancer progressed (advanced invasive > early invasive > noninvasive). The positive staining of P54 were mainly located in the cytoplasm, especially around the nucleus. There was no significant stained region in the cell matrix. The P54 localization in the cytoplasm was verified by confocal experiment, and the PAK4 was co-localized. CONCLUSIONS: PAK4 and P54 proteins may be used as molecular markers for diagnosis and treatment of breast cancer.
format Online
Article
Text
id pubmed-4906770
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49067702016-06-15 Study on the expression of PAK4 and P54 protein in breast cancer Bi, Yanqing Tian, Mengzi Le, Jinghong Wang, Linlin Liu, Xiaofang Qu, Jianhua Hao, Min World J Surg Oncol Research BACKGROUND: Previous evidence have demonstrated that p21-activated kinase PAK4 was correlated with breast cancer. The aim of this paper is to study the expression and interaction of p21-activated kinase (pAK)-4 and P54 protein in breast cancer. METHODS: A total of 80 patients were enrolled in our study (breast fibroma n = 20, breast noninvasive cancer n = 20, early breast invasive cancer n = 20, and advanced breast invasive cancer). The expression of PAK4 was detected by immunohistochemical S-P method, and the relationship between them and the different pathological characteristics were compared. The subcellular localization of P54 and PAK4 in vitro was observed by immunofluorescence assay. RESULTS: The expression of both PAK4 and P54 in breast cancer was much higher than that in breast fibroma. Meanwhile, we found that both PAK4 and P54 increased gradually as breast cancer progressed (advanced invasive > early invasive > noninvasive). The positive staining of P54 were mainly located in the cytoplasm, especially around the nucleus. There was no significant stained region in the cell matrix. The P54 localization in the cytoplasm was verified by confocal experiment, and the PAK4 was co-localized. CONCLUSIONS: PAK4 and P54 proteins may be used as molecular markers for diagnosis and treatment of breast cancer. BioMed Central 2016-06-13 /pmc/articles/PMC4906770/ /pubmed/27297086 http://dx.doi.org/10.1186/s12957-016-0913-6 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Bi, Yanqing
Tian, Mengzi
Le, Jinghong
Wang, Linlin
Liu, Xiaofang
Qu, Jianhua
Hao, Min
Study on the expression of PAK4 and P54 protein in breast cancer
title Study on the expression of PAK4 and P54 protein in breast cancer
title_full Study on the expression of PAK4 and P54 protein in breast cancer
title_fullStr Study on the expression of PAK4 and P54 protein in breast cancer
title_full_unstemmed Study on the expression of PAK4 and P54 protein in breast cancer
title_short Study on the expression of PAK4 and P54 protein in breast cancer
title_sort study on the expression of pak4 and p54 protein in breast cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906770/
https://www.ncbi.nlm.nih.gov/pubmed/27297086
http://dx.doi.org/10.1186/s12957-016-0913-6
work_keys_str_mv AT biyanqing studyontheexpressionofpak4andp54proteininbreastcancer
AT tianmengzi studyontheexpressionofpak4andp54proteininbreastcancer
AT lejinghong studyontheexpressionofpak4andp54proteininbreastcancer
AT wanglinlin studyontheexpressionofpak4andp54proteininbreastcancer
AT liuxiaofang studyontheexpressionofpak4andp54proteininbreastcancer
AT qujianhua studyontheexpressionofpak4andp54proteininbreastcancer
AT haomin studyontheexpressionofpak4andp54proteininbreastcancer